首页> 美国卫生研究院文献>The Journal of Clinical Investigation >Spastic paraplegia proteins spastizin and spatacsin mediate autophagic lysosome reformation
【2h】

Spastic paraplegia proteins spastizin and spatacsin mediate autophagic lysosome reformation

机译:痉挛性截瘫蛋白spastizin和spatacsin介导自噬溶酶体再形成

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Autophagy allows cells to adapt to changes in their environment by coordinating the degradation and recycling of cellular components and organelles to maintain homeostasis. Lysosomes are organelles critical for terminating autophagy via their fusion with mature autophagosomes to generate autolysosomes that degrade autophagic materials; therefore, maintenance of the lysosomal population is essential for autophagy-dependent cellular clearance. Here, we have demonstrated that the two most common autosomal recessive hereditary spastic paraplegia gene products, the SPG15 protein spastizin and the SPG11 protein spatacsin, are pivotal for autophagic lysosome reformation (ALR), a pathway that generates new lysosomes. Lysosomal targeting of spastizin required an intact FYVE domain, which binds phosphatidylinositol 3-phosphate. Loss of spastizin or spatacsin resulted in depletion of free lysosomes, which are competent to fuse with autophagosomes, and an accumulation of autolysosomes, reflecting a failure in ALR. Moreover, spastizin and spatacsin were essential components for the initiation of lysosomal tubulation. Together, these results link dysfunction of the autophagy/lysosomal biogenesis machinery to neurodegeneration.
机译:自噬通过协调细胞组分和细胞器的降解和循环来维持体内平衡,从而使细胞适应环境变化。溶酶体是细胞器,通过与成熟的自噬体融合产生可降解自噬物质的自溶体,是终止自噬的关键。因此,维持溶酶体群体对于自噬依赖性细胞清除至关重要。在这里,我们已经证明,两种最常见的常染色体隐性遗传性痉挛性截瘫基因产物,SPG15蛋白spastizin和SPG11蛋白spatacsin,对于自噬溶酶体重组(ALR)至关重要,ALR是一种产生新溶酶体的途径。靶向spastizin的溶酶体靶向需要一个完整的FYVE结构域,该结构域结合磷脂酰肌醇3-磷酸。失去spastizin或spatacsin导致能与自噬体融合的游离溶酶体的消耗,以及溶酶体的积累,反映了ALR的失败。此外,spastizin和spatacsin是启动溶酶体输卵管的必不可少的成分。总之,这些结果将自噬/溶酶体生物发生机制的功能障碍与神经变性联系在一起。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号